Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis.
Palavani LB, Silva GM, Borges PGLB, Ferreira MY, Sousa MP, Leite MGHSJ, Oliveira LB, Batista S, Bertani R, Polverini AD, Beer-Furlan A, Paiva W.
J Neurooncol. 2024 May;167(3):373-385. doi: 10.1007/s11060-024-04621-6. Epub 2024 Mar 8.
Stereotactic radiosurgery and fractionated radiotherapy for spinal arteriovenous malformations - A systematic review of the literature.
Zhan PL, Jahromi BS, Kruser TJ, Potts MB.
J Clin Neurosci. 2019 Apr;62:83-87. doi: 10.1016/j.jocn.2018.12.014. Epub 2019 Jan 21.
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Yan M, Louie AV, Kotecha R, Ashfaq Ahmed M, Zhang Z, Guckenberger M, Kim MS, Lo SS, Scorsetti M, Tree AC, Sahgal A, Slotman BJ.
Lung Cancer. 2023 Aug;182:107281. doi: 10.1016/j.lungcan.2023.107281. Epub 2023 Jun 21.
Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O, Bartek J Jr, Shalom NB, Wangerid T, Jakola AS, Förander P.
Acta Neurochir (Wien). 2017 Jun;159(6):1013-1021. doi: 10.1007/s00701-017-3164-6. Epub 2017 Apr 13.
Fractionated CyberKnife Stereotactic Radiotherapy for Perioptic Pituitary Adenomas.
Plitt AR, El Ahmadieh TY, Aoun SG, Wardak Z, Barnett SL.
World Neurosurg. 2019 Jun;126:e1359-e1364. doi: 10.1016/j.wneu.2019.03.102. Epub 2019 Mar 19.
Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis.
Nguyen T, Duong C, Sheppard JP, Lee SJ, Kishan AU, Lee P, Tenn S, Chin R, Kaprealian TB, Yang I.
Clin Neurol Neurosurg. 2018 Mar;166:116-123. doi: 10.1016/j.clineuro.2018.01.005. Epub 2018 Jan 12.
Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis.
Ehret F, Rueß D, Blanck O, Fichte S, Chatzikonstantinou G, Wolff R, Mose L, Mose S, Fortmann T, Lehrke R, Turna M, Caglar HB, Mortasawi F, Bleif M, Krug D, Ruge MI, Fürweger C, Muacevic A.
Int J Cancer. 2024 Sep 1;155(5):916-924. doi: 10.1002/ijc.34980. Epub 2024 May 8.
Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs.
Hansen KS, Théon AP, Willcox JL, Stern JA, Kent MS.
Vet Comp Oncol. 2021 Mar;19(1):191-200. doi: 10.1111/vco.12662. Epub 2020 Nov 12.
Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: A systematic review and meta-analysis.
Li X, Li Y, Cao Y, Li P, Liang B, Sun J, Feng E.
J Neurol Sci. 2017 Jan 15;372:110-116. doi: 10.1016/j.jns.2016.11.024. Epub 2016 Nov 15.
Organs at risk radiation dose constraints.
Noël G, Antoni D.
Cancer Radiother. 2022 Feb-Apr;26(1-2):59-75. doi: 10.1016/j.canrad.2021.11.001. Epub 2021 Dec 23.
